Thursday, June 6, 2013

FDA Avandia Panel: A Twitter-Based Review

An FDA advisory panel is currently meeting to analyst a re-analysis of a clinical trial of the GlaxoSmithKline drug Avandia. For a summary of why this is important, read my piece from last night. This is a summary of what happened, culled from my tweets and those of others.

?

?

?

Source: http://www.forbes.com/sites/matthewherper/2013/06/05/fda-avandia-panel-a-twitter-based-review/

arrested development arrested development Champions League Everett Golson Tim Duncan June Carter monsanto

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.